Open house Arzneimittelrabattverträge Somatropin, ATC H01AC01
Titre original de l'avis
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Somatropin, ATC H01AC01
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
20 / 100
Facteurs de risque
No volume commitment; actual business depends on prescription behavior and patient needs.
Open house agreements can be overridden by later competitive discount contracts, potentially reducing or eliminating th...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Strong opportunityFaits clés
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Apr 2027
- Supply of Somatropin (ATC H01AC01) pharmaceutical products under non-exclusive discount agreements with AOK Bayern
- Agreements are governed by §130a Abs. 8 SGB V
Afficher le résumé complet
This is an open house (non-competitive) procedure by AOK Bayern for non-exclusive discount agreements on Somatropin (ATC H01AC01) pharmaceutical products. Any qualified pharmaceutical company can join by submitting a signed contract and a self-declaration of reliability. Contracts run from May 2025 to April 2027, with possible later start if signed later. No estimated value is provided. The notice is published as an open procedure due to lack of an open house form, but the procedure is not subject to procurement law.
Risques
No volume commitment; actual business depends on prescription behavior and patient needs.
Open house agreements can be overridden by later competitive discount contracts, potentially reducing or eliminating th...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Eligibility
- Only pharmaceutical companies are eligible
Administrative
- Submit signed contract and self-declaration of reliability
- Documents must be submitted either in paper (two signed originals) or electronically with qualified electronic signature via the communication area of dtvp.de
Les exigences peuvent être incomplètes.
Acheteur
Localisation
München, DEU
Site web
Profil acheteur
Identifiant
DE811695320
Activité
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Somatropin, ATC H01AC01
Non-exclusive discount agreements for Somatropin, valid for Bavaria. Contracts are open to all qualified pharmaceutical companies. No competitive selection.
Localisation
Durée
Catégorie
Date limite
Détails des critères
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Note sur la valeur
Afficher les données TED originales
Description TED originale
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Détails de la procédure
- Date de publication
- 18 Mar 2025
- Langues
- German
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 177454-2025
Documents (2)
Appels d'offres similaires
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
20 / 100
Facteurs de risque
No volume commitment; actual business depends on prescription behavior and patient needs.
Open house agreements can be overridden by later competitive discount contracts, potentially reducing or eliminating th...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications